Inactive Instrument

Highlights DermTech, Inc. Nasdaq

Equities

VGG2379F1247

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Earnings Flash (DMTK) DERMTECH Posts Q1 Revenue $3.8M	May. 14	MT
North American Morning Briefing : Stock Futures -2-	Apr. 22	DJ
DermTech Explores Strategic Alternatives to Boost Shareholder Value, Lays Off 100 Employees in Restructuring Plan	Apr. 18	MT
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan	Apr. 17	CI
DermTech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
DermTech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Earnings Flash (DMTK) DERMTECH Reports Q4 Revenue $3.9M, vs. Street Est of $4.03M	Feb. 29	MT
DermTech Announces Positive Topline Results from A Study Evaluating the Dermtech Melanoma Test Across All Skin Types	Jan. 18	CI
DermTech, Inc. Simplifies the DermTech Melanoma Test by Discontinuing the Optional TERT Add-On Assay	Jan. 16	CI
Dermtech Announces Positive Topline Results from Trust 2 Study Evaluating the Dermtech Melanoma Test	Jan. 08	CI
DermTech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Earnings Flash (DMTK) DERMTECH Posts Q3 Revenue $3.9M, vs. Street Est of $3.9M	Nov. 02	MT
DermTech Inc Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test	23-09-19	CI
DermTech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
Earnings Flash (DMTK) DERMTECH Posts Q2 Revenue $4M, vs. Street Est of $3.7M	23-08-03	MT
DermTech, Inc. Announces ECRI Complete Its Evaluation of the Pigmented Lesion Assay	23-06-14	CI
DermTech Signs Agreement With Hawaii Blues Plan to Enhance Melanoma Test Access	23-06-07	MT
DermTech, Inc. Announces Contract with Hawaii Blues Plan for the Foundational Assay of Its Dermtech Melanoma Test	23-06-07	CI
DermTech, Inc. Announces Agreements with South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test	23-05-11	CI
DERMTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-05-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DermTech, Inc. Nasdaq

Equities

VGG2379F1247

Highlights

Filters